Literature DB >> 1819612

Medical status of patients attending a primary care dental practice in Ireland.

M R Fenlon1, B E McCartan.   

Abstract

Medical status of 1,500 patients attending a primary health care dental practice was examined by means of patient self-completed health questionnaire and by structured verbal interview by a dentist. Relevant medical histories and/or drug therapies affecting the practices of dentistry were found in 27.7% of patients. Problems identified included cardiovascular disease (10.4%), endocarditis risks (5.8%), hepatitis (7.9%), leukaemias (0.3%), bleeding tendencies (3%), drug allergies (7.0%), including penicillin allergy (3.6%) and intake of drugs affecting dentistry (6.0%). For most of these categories there was a marked increase in prevalence with increasing age and many categories contained many more women than could be expected from the male/female distribution of the total patient group.

Entities:  

Mesh:

Year:  1991        PMID: 1819612

Source DB:  PubMed          Journal:  J Ir Dent Assoc        ISSN: 0021-1133


  4 in total

Review 1.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

2.  Medical Conditions, Oral Health Practices, and Barriers to Treatment among Patients Visiting a Teaching Dental Hospital in Eastern Saudi Arabia.

Authors:  Faisal A Alonaizan; Khalid Almas; Muhammad Ashraf Nazir; Dalal Almazrou; Manar Alzamil; Mohammed A AlOlyani
Journal:  ScientificWorldJournal       Date:  2022-02-04

3.  The frequency of medically compromised patients in endodontic offices in iran.

Authors:  Masoud Parirokh; Mohammad Jafar Eghbal; Jamileh Ghoddusi; Shahla Kakoei; Ali Akbar Haghdoost; Sina Kakooei
Journal:  Iran Endod J       Date:  2013-05-01

4.  Medical status of patients presenting for treatment at an Australian dental institute: a cross-sectional study.

Authors:  Agnieszka M Frydrych; Richard Parsons; Omar Kujan
Journal:  BMC Oral Health       Date:  2020-10-21       Impact factor: 2.757

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.